Significant and Durable Clinical Response to Sorafenib and Radiation Therapy for a Patient With Stage IV Hepatocellular Carcinoma and
LRRK2
Mutation
JCO Precis Oncol
.
2019 Mar 11:3:PO.18.00277.
doi: 10.1200/PO.18.00277.
eCollection 2019.
Authors
Linlin Yang
1
,
Patrick Wald
1
,
Sameek Roychowdhury
1
,
Anne M Noonan
1
,
Li Zuo
2
3
4
,
Chia-Chen Chuang
2
4
,
Julie Reeser
1
,
Evan Wuthrick
1
5
,
Carl Schmidt
1
,
Terence Williams
1
Affiliations
1
Wexner Medical Center, The Ohio State University, Columbus, Ohio.
2
College of Medicine, The Ohio State University, Columbus, OH.
3
College of Arts and Sciences, University of Maine, Presque Isle, ME.
4
Interdisciplinary Biophysics Graduate Program, The Ohio State University, Columbus, OH.
5
Moffitt Cancer Center, Tampa, FL.
PMID:
32914030
PMCID:
PMC7446478
DOI:
10.1200/PO.18.00277
No abstract available
Publication types
Case Reports